Penile Prosthesis in Patients With Erectile Dysfunction
NCT ID: NCT03466619
Last Updated: 2018-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
100 participants
INTERVENTIONAL
2014-11-01
2027-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inflatable Penile Prostheses : Which Patients Can Correctly Use the Scrotal Pump ?
NCT04390230
Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction
NCT03849586
Penile Implant Intraoperative Measurements Planning Chart
NCT05531877
External Device for Erectile Dysfunction (3D-Erect)
NCT04624126
Combined Effect of Continuous and Interval in Addition to Tadalafil Drug on Erectile Dysfunction
NCT04623840
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
inflatable penile prosthesis (IPP)
inflatable penile prosthesis (IPP)
inflatable penile prosthesis (IPP)
inflatable penile prosthesis (IPP)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
inflatable penile prosthesis (IPP)
inflatable penile prosthesis (IPP)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* General contraindications as uncorrectable bleeding tendency
18 Years
80 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sherief Abd-Elsalam
Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Khaled Mohamed Hafez Morsy Almekaty, Msc
Role: PRINCIPAL_INVESTIGATOR
Urology Department- Tanta University
Samir Abdelhakim Elgamal, Prof
Role: PRINCIPAL_INVESTIGATOR
Urology Department- Tanta University
Suks Minhas, Prof
Role: PRINCIPAL_INVESTIGATOR
Professor of urology University College London Hospital(UCLH)London, UK
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta university - faculty of medicine
Cairo, Elgharbia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Khaled Hafez
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.